MedPlus Health Services Limited (formerly known as MedPlus Health Services Private Limited)
Annexure- VIL

Notes to Restated Consolidated Financial Information

(All amounts are it Rs in millions except as others stated)

43. Related party Disclosure (continued)
(a) Transactions within the Group (these transactions got eliminated in Restated Consolidated Financial Information)

 

 

 

 

 

 

September 302021 September 302020 March 312021 March 31,2020 Marchi, 2019
(0) Transaction by the Company with other Group entities:

1. Optival Health Solutions Private Limited

Rental income 103 079 159 an 159
Rental expenses [including GST of Re31 millions (September 0, 2020: GST of Rs: 0.22)

(ch 3p “Cot a 0. aon) ach 3.20087 of 1 mon 28 uw a0 28 1
Guarantee given on behalf of (refer note no, 36) 3 75.00 75.00 725.00 1,050.00
Management services rendered 1672 m7 281 22.46 1908
Investment in subsidiary - : - 1,870.00 -
Share application money refunded - - : - :
Pathological Testing Services rendered 3 _ 2 0s 009
Brand Fee received 207 215 4504 4159 43.0
Reimbursement of Expenses : - 076 - :
Sale of traded goods (net of taxes) 125.66 - 154.69 - :
Software under development{ including GST of Rs 0.97 milions( September 30, 2020: GST

of Rs: Nil) B36 ° 2 ° 2
Deemed investment

Corporate Guarantee income 407 456 ear 736 561
Share-based payment expense 507 25.14 235.2 076 13.60
2. MHS Pharmaceuticals Private Limited

Management services rendered 0s 036 oss oss ost
Rental income . 05 006 010 010
Rental expenses os 2 298 - :
Parchase consideration for business transfer pursuant to BTA - - 19504 - :
Purchase of Asset 2 ‘ 328 - :
Parchase of traded goods (nt of taxes) 2 - 12 - :
Investment in subsidiary 2 _ 7 40.00 30.00
SShare-based payment expense 2 179 179 é 012
43. Agilemed Investments Private Limited

Rental income 2 oo. 02 002 02
Investment in subsidiary - : 082 - -
Unsecured loan given and refund received (refer note 56) 2 500 500 - :
Interest on unsecured loan 2 3 009 - :
Issue of bonus shares (series BI CCPS) 2 - 6107 - :
5. Wynclark Pharmaceuticals Private Limited

Management services rendered 029 02 020 - -
Reimbursement of expenses to oo. 02 02 002 on
Reimbursement of expenses by - - - - -
Investment in subsidiary - : 1000 500 :
6. Venkata Krishna Enterprises Private Limited

Share-based payment expense 2 536 536 i 037
7. Kalyani Meditimes Private Limited

Investment in subsidiary - 2 750 2230 -
Loan given and converted into equity shares ; i" : 520 -
Unsecured loan given (refer note 56) 1200 450 450 - :
Interest on unsecured loan 1105 003 oss - :
Revenue from Services (excluding x) 030 2 - . :
8. NovaSud Pharmaceuticals Private Limited

Investment in subsidiary - 2 5.00 - -
9, Sidson Pharma Distributors Private Limited

Unsecured loan extended 2 i 0.00 - -
Unsecured loan received back 2 ‘ 0.00 ‘ 2
Interest on unsecured loan 2 ‘ 099 - :
10. Ritemed Pharma Retail Private Limited *

Management services rendered 2 i 2 i 168
Rental income 2 ‘ 2 ‘ 05
Rental expenses = ‘ 2 ‘ 00s
Pathological testing services rendered 2 ‘ 2 ‘ oot
Brand Fee received 2 ‘ 2 ‘ 526
Deemed investment

Corporate Guarantee income 2 i 2 i 03s
SShare-based payment expense 2 ‘ 2 ‘ 294
1, Clearancekart private Limited

Investment in subsidiary 010 2 - - -

“The Company was merged with Optival Health Solutions Private Limited w.e4. April 01,2016 based on the NCLT order received in 2018-19)

267
